Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti–IL-5 antibody SCH55700
- 1 December 2004
- journal article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 114 (6), 1449-1455
- https://doi.org/10.1016/j.jaci.2004.08.027
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Safety and efficacy of the monoclonal anti–interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndromeBlood, 2004
- Use of an Anti–Interleukin-5 Antibody in the Hypereosinophilic Syndrome with Eosinophilic DermatitisNew England Journal of Medicine, 2003
- Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsivenessBlood, 2003
- Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndromeBlood, 2003
- Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disordersBlood, 2003
- A Tyrosine Kinase Created by Fusion of thePDGFRAandFIP1L1Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic SyndromeNew England Journal of Medicine, 2003
- Eosinophilic GastroenteritisJournal of Pediatric Gastroenterology and Nutrition, 2000
- Eosinophilic GastroenteritisSouthern Medical Journal, 1996
- Response of six patients with idiopathic hypereosinophilic syndrome to interferon alfa*Journal of Allergy and Clinical Immunology, 1994
- THE HYPEREOSINOPHILIC SYNDROMEMedicine, 1975